| Active Pharmaceutical Ingredients and Intermediates | Manufacture of bulk generic APIs and intermediates for generic and innovator pharma companies | Robust regulatory approvals, SEZ-based manufacturing, strong R&D, long-standing client relationships | Pharmaceutical manufacturers (B2B) globally including innovator pharma companies | Custom synthesis and specialized intermediates for patented drugs | 8500 | 91 | Sales through long-term contracts and orders from pharmaceutical companies worldwide | Contract and project-based pricing, long-term supply agreements | Increasing global pharmaceutical demand, backward integration efforts, expanded capacities | Not individually branded; bulk APIs supplied globally |
| Nutraceutical Ingredients | Production and marketing of nutraceutical ingredients for dietary supplements and food industries | Global marketing reach via subsidiaries and regulatory compliant manufacturing | Nutraceutical, dietary supplement companies (B2B) primarily in North America and Europe | High purity, specialty nutraceutical compounds | 860 | 9 | Sales through subsidiaries in USA and Europe targeting nutraceutical manufacturers | Direct sales and supply contracts | Rising global demand for health supplements and functional food ingredients | Marketed through subsidiaries Divis Laboratories (USA) Inc and Divi's Laboratories Europe AG |
